Mercedes-Benz India posts record sales at 4,697 units in March quarter Mercedes-Benz India, which had sold 4,022 units in the same quarter last year, launched its hybrid AMG GT 63 S ... Benz India ...

Godzilla strikes again. A legendary Nissan R32 GT-R goes all-out on the Nürburgring, pushing not one—but TWO Porsche GT3 RS ...

Two turbocharged legends go head-to-head on the 1/4 mile strip! 🏁 Porsche 911 Turbo 997 vs Nissan GT-R – classic vs modern ...

A 16-unit affordable housing project slated for a parcel near the Willits Rugby Field unanimously passed sketch plan review at Tuesday’s Basalt Town Council meeting. Known as Parcel 9 ...

Nissan Motor Co., Ltd., will pull back from Europe and elsewhere to focus on the United States, China and Japan under a plan that represents ... though we reduce our R&D spend this year versus ...

The programmable screen also shows GT-R performance data like turbo boost pressure, engine oil temperature, fuel flow rate, and transmission fluid temperature. ₱8,800,000 is the highest price for a ...

Site plans obtained by the Times-Tribune suggest up to six two-story buildings and two on-site substations could be developed. The application references seven data center buildings, but the actual ...

In less than a year he transformed a wrecked GT3 into one of the most impressive custom Porsche builds that you will ever see ...

The Bethlehem Planning Commission reviewed a plan for 608 Pierce St., submitted by real estate developer Dallas Basha. The applicant listed on the project's sketch plans previously submitted to ...

The developer submitted its sketch plan for the Archbald Planning Commission ... The parking lot and ponds are in an R-2 medium density residential district. Data centers are principally permitted ...

Ford's best-selling Puma SUV has gone all-electric. Will the sub-£30k Puma Gen-E become Ford's first best-seller EV? Freda ...

AstraZeneca has revealed plans to set up a new strategic R&D hub in Cambridge, Massachusetts as it reported a massive increase in first-quarter revenues, driven by COVID-19 and oncology drugs and ...